fangdie ye

Dr. fangdie ye


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in Environmental Toxicology
Verified
Journal Article
Closed access
ZSZhou Sun
Zhou Sun
JWJie Wang
Jie Wang
QZQiang Zhang
Qiang Zhang
XMXiangdi Meng
Xiangdi Meng
ZMZhaosen Ma
Zhaosen Ma
BMBaoluo Ma
Baoluo Ma

27 October 2023 in Environmental Toxicology
Verified
Journal Article
Closed access
BMBaoluo Ma
Baoluo Ma
LQLinghui Qin
Linghui Qin
ZSZhou Sun
Zhou Sun
JWJingyu Wang
Jingyu Wang
LTLisa Jia Tran
Lisa Jia Tran
MCMin Chen
Min Chen

10 October 2023 in Discover Oncology
Verified
Journal Article
Open access
PDF file
CZChengcun Zhu
Chengcun Zhu
ZSZhou Sun
Zhou Sun
JWJie Wang
Jie Wang
XMXiangdi Meng
Xiangdi Meng
ZMZhaosen Ma
Zhaosen Ma
BMBaoluo Ma
Baoluo Ma
G protein-coupled receptors (GPCRs) are a class of receptors on cell membranes that regulate various biological processes in cells, such as cell proliferation, differentiation, migration, apoptosis, and metabolism, by interacting with G proteins. However, the role of G protein-coupled receptors in predicting the prognosis of renal clear cell carcinoma is still unknown. The transcriptome data and clinical profiles of renal clear cell carcinoma patients, were downloaded from TCGA databases, and the validation group data were downloaded from number GSE167573, including 63 tumor samples and 14 normal samples. Single-cell RNA sequencing data were downloaded from the GEO database, No. GSE152938 and selected samples were used for GSEA enrichment analysis, WGCNA subgroup analysis, single-cell data analysis, and mutation analysis to explore the role of G protein-coupled receptor-related genes in the diagnosis and prognosis of renal clear cell carcinoma and to verify their reliability with cellular experiments. Finally, this study establishes a disease model based on G protein-coupled receptor-related genes, which may help to propose targeted therapeutic regimens in different strata of renal cell carcinoma patients.Author names: Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author: Given name [Lisa Jia] Last name [Tran].It's ok!

6 November 2023 in Aging
Verified
Journal Article
Open access
PDF file
JWJie Wang
Jie Wang
ZZZili Zuo
Zili Zuo
ZYZongze Yu
Zongze Yu
ZCZhigui Chen
Zhigui Chen
LTLisa Jia Tran
Lisa Jia Tran
ZSZhou Sun
Zhou Sun
Introduction: Gaining a deeper insight into the single-cell RNA sequencing (scRNA-seq) results of bladder cancer (BLCA) provides a transcriptomic profiling of individual cancer cells, which may disclose the molecular mechanisms involved in BLCA carcinogenesis. Methods: scRNA data were obtained from GSE169379 dataset. We used the InferCNV software to determine the copy number variant (CNV) with normal epithelial cells serving as the reference, and performed the pseudo-timing analysis on subsets of epithelial cell using Monocle3 software. Transcription factor analysis was conducted using the Dorothea software. Intercellular communication analysis was performed using the Liana software. Cox analysis and LASSO regression were applied to establish a prognostic model. Results: We investigated the heterogeneity of tumors in four distinct cell types of BLCA cancer, namely immune cells, endothelial cells, epithelial cells, and fibroblasts. We evaluated the transcription factor activity of different immune cells in BLCA and identified significant enrichment of TCF7 and TBX21 in CD8+ T cells. Additionally, we identified two distinct subtypes of cancer-associated fibroblasts (CAFs), namely iCAFs and myoCAFs, which exhibited distinct communication patterns. Using sub-cluster and cell trajectory analyses, we identified different states of normal-to-malignant cell transformation in epithelial cells. TF analysis further revealed high activation of MYC and SOX2 in tumor cells. Finally, we identified five model genes (SLCO3A1, ANXA1, TENM3, EHBP1, LSAMP) for the development of a prognostic model, which demonstrated high effectiveness in stratifying patients across seven different cohorts. Conclusions: We have developed a prognostic model that has demonstrated significant efficacy in stratifying patients with BLCA.

23 March 2024 in Cellular Oncology
Verified
Journal Article
Closed access
PDF file
HHHe Huang
He Huang
QLQian Li
Qian Li
XTXusheng Tu
Xusheng Tu
DYDongyue Yu
Dongyue Yu
YZYundong Zhou
Yundong Zhou
CKChunlian Ke
Chunlian Ke

12 March 2021 in Research Square
Verified
Preprint
Open access
PDF file
FYfangdie ye
fangdie ye
YLYingchun Liang
Yingchun Liang
ZCZhang Chen
Zhang Chen
YLYufei Liu
Yufei Liu
HJHaowen Jiang
Haowen Jiang
Background: Forkhead box protein f1 (Foxf1) is associated with oncogenesis, and maybe play a key role in prostate cancer. However, the effect of Foxf1 on the development of prostate cancer and its clinical implications were still unknown. Method: The transcriptome data and clinical information were downloaded from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO). The differential co-expression genes which were the most closely correlated with prostate cancer were identified by weighted gene co-expression network analysis (WGCNA) and differential expression analysis method. The univariate cox regressions were performed to identify the prognostic genes. Finally, Foxf1 were verified in clinical tumor samples and matched normal tissues. Results: A total of 108 differential co-expression genes were identified. Foxf1 was identified that significantly associated with overall survival rate and biochemical recurrence of prostate. Then, protein-protein interaction (PPI) networks were constructed, including 21 nodes and 26 edges. The data revealed GAPVD1, MIR522, MIR937, CPS1, HOXB9, FUBP3, MIR936, SDF4, SATB2, HOXB13, MIR375, PUSL1, SATB1, MIR382, MIR429, HOXD13, PRSS50, FLNC, STRBP, KHSRP were significant associated with the regulation and function of differentially expressed Foxf1 in prostate. The experimental results confirmed the Foxf1 were downregulated in the prostate cancer tissues compared with the matched normal tissues.Conclusion: we obtained a gene Foxf1 which is significantly related with the prognosis of prostate cancer, Foxf1 have significant values in predicting the patients’ Overall survival and may serve as a potential prognosis biomarker and a new therapeutic target of prostate cancer.